Cargando…
Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer
OBJECTIVE: To evaluate the efficacy of bevacizumab a monoclonal, antivascular endothelial growth factor antibody in combination with cytotoxic chemotherapy in Turkish patients with recurrent and metastatic cervical cancer. MATERIALS AND METHODS: Data of 64 patients with metastatic or recurrent cervi...
Autores principales: | Ercelep, Özlem, Tataroğlu, Deniz, Özçelik, Melike, Sürmeli, Heves, Değirmenci, Mustafa, İnanç, Mevlüde, Aliustaoğlu, Mehmet, Gümüş, Mahmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406906/ https://www.ncbi.nlm.nih.gov/pubmed/32850187 http://dx.doi.org/10.4274/tjod.galenos.2020.90699 |
Ejemplares similares
-
PTK-7 Expression in Gastric Cancer: A Prognostic Determinant
por: Özçelik, Melike, et al.
Publicado: (2020) -
Patient satisfaction in the outpatients' chemotherapy unit of Marmara University, Istanbul, Turkey: a staff survey
por: Turhal, Nazim S, et al.
Publicado: (2002) -
Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?
por: Odabas, Hatice, et al.
Publicado: (2023) -
Normal echocardiographic measurements in a Turkish population: The Healthy Heart ECHO-TR Trial
por: Şafak, Özgen, et al.
Publicado: (2019) -
The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel Adenocarcinomas
por: Aydin, Dincer, et al.
Publicado: (2023)